Hoerter Steven L.
- SEC CIK
- 0001533451
In the past year, 1 open-market purchase filing worth $265.0K and no sales.
Current role at each company
- MBX MBX Biosciences, Inc.President and CEOas of Aug 4, 2026
- CCCC C4 Therapeutics, Inc.Directoras of Jun 26, 2026
- ORIC Oric Pharmaceuticals, Inc.Directoras of Jan 6, 2026
- DCPH Deciphera Pharmaceuticals, Inc.President and CEOas of Jun 11, 2024
- CNST Constellation Pharmaceuticals IncDirectoras of Jul 23, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $265.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$265.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Hoerter Steven L. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MBX MBX Biosciences, Inc.
President and CEO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2025 (view filing) | Oct 17 | 3 days | Hoerter Steven L.Director | PPurchase | +20.0K | $13.25 | +$265.0K | New position20.0K after |
DCPH Deciphera Pharmaceuticals, Inc.
President and CEO4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 14, 2023 (view filing) | Dec 13 | 1 day | Hoerter Steven L.President and CEO | SSale | −30.7K | $15.37 | −$471.3K | −29.6%72.8K after | |
| Oct 31, 2023 (view filing) | Oct 30 | 1 day | Hoerter Steven L.President and CEO | SSale | −21.6K | $12.02 | −$259.3K | −34.5%40.9K after | |
| Mar 23, 2023 (view filing) | Mar 21 | 2 days | Hoerter Steven L.President and CEO | SSale | −7.50K | $15.57 | −$116.8K | −100.0%0 after | |
| Feb 16, 2023 (view filing) | Feb 14 | 2 days | Hoerter Steven L.President and CEO | SSale | −30.0K | $16.00 | −$480.7K | −80.0%7.50K after |